Mega Genomics Limited (HKG:6667)
7.02
-0.11 (-1.47%)
Sep 30, 2026, 3:48 PM HKT
Mega Genomics Market Cap
Mega Genomics has a market cap or net worth of 1.57 billion as of October 1, 2026. Its market cap has decreased by -3.05% in one year.
Market Cap
1.57B
Enterprise Value
1.11B
Revenue
413.73M
Ranking
n/a
PE Ratio
48.95
Stock Price
7.02
ChartMarket Cap Chart
Since June 22, 2022, Mega Genomics's market cap has decreased from 4.31B to 1.57B, a decrease of -63.64%. That is a compound annual growth rate of -21.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 1.57B | -37.50% |
| Dec 31, 2024 | 2.50B | 2.28% |
| Dec 29, 2023 | 2.45B | -21.25% |
| Dec 30, 2022 | 3.11B | -27.78% |
| Jun 22, 2022 | 4.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 103.84B |
| Adicon Holdings | 3.33B |
| Kindstar Globalgene Technology | 920.32M |
| China Biotech Services Holdings | 595.20M |
| Biosino Bio-Technology and Science Incorporation | 464.51M |
| China NT Pharma Group Company | 389.09M |
| Zhong Ji Longevity Science Group | 305.59M |
| Yunkang Group | 269.26M |